Emergency Call for Heart Attack and Stroke (ECHAS) - ECHAS One Study

NCT ID: NCT05230069

Last Updated: 2022-02-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-04-01

Study Completion Date

2022-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

ECHAS One will test the use of a smartphone app to assist patients to decide if it is necessary to call for emergency care with symptoms that could represent a heart attack or stroke.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The ECHAS One Study will be conducted in 200 patients who have already called for emergency care for a heart or stroke, and have been evaluated. The endpoint of the study will be a decision if the initial call was an appropriate call for emergency care. The sensitivity of the app for detecting appropriate calls will be assessed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Attack and Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients post emergency evaluation

Interview of patients post notification of emergency system

Interview

Intervention Type OTHER

Patients will be interviewed post an emergency call and evaluation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Interview

Patients will be interviewed post an emergency call and evaluation.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Presented to ED via emergency medical services (EMS) for "Stroke alert" symptoms, including:

Slurred speech Asymmetric weakness or numbness Balance problems Vision changes Headache

And/or "MI alert" symptoms including:

Chest discomfort Chest pressure or pain Palpitations Shortness of breath Lightheadedness or presyncope Syncope Age ≥ 18 years Able to provide informed consent

Exclusion Criteria

* Non-English speaking
* Moderate or greater dementia
* Severe visual impairment
* Inability to use smartphone (for physical, cognitive, or other reasons)
* Unable to consent for study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Saskatchewan

OTHER

Sponsor Role collaborator

Emergency Call for Heart Attack and Stroke (ECHAS)

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

James E Muller

Role: STUDY_DIRECTOR

CEO, ECHAS, LLC

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

James E Muller

Role: CONTACT

6177178570

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ECHAS One

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Low-Risk Chest Pain Echo Study
NCT05785923 UNKNOWN NA